References
- Allen J M, Adrian T E, Webster J, Howe A, Bloom S R. Effect of a single dose of omeprazole on the gastrointestinal peptide response to food. Hepato-gastroenterol 1984; 31: 44–46
- Koop H, Schwarting H, Knorr-Marin A, Willhardt C, Möser T, Arnold R. Influence of chronic omeprazole treatment on gastric endocrine function. Klin Wochenschr 1987; 65: 169–173
- Saffouri B, Weir G C, Bitar K N, Makhlouf G M. Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides. Am J Physiol 1980; 238: G495–G501
- Demol P, Wingender W, Weihrauch T R, Graefe K H. Inhibition of gastric secretion in man by riop-rostil, a new synthetic methyl prostaglandin E. Arzneim Forsch/Drug Res 1985; 35: 861–863
- Creutzfeldt W, Arnold R, Creutzfeldt C, Track N S. Mucosal gastrin concentrition, molecular forms of gastrin, number and ultrastructure of G-cells in patients with duodenal ulcer. Gut 1976; 17: 745–754
- McIntosh C, Arnold R, Bothe E, Becker H, Kob-Berling J, Creutzfeldt W. Gastrointestinal somatostatin: extraction and radioimmunoassay in different species. Gut 1978; 19: 655–663
- Mayer G, Arnold R, Feurle G, Fuchs K, Ketterer H, Track N S, Creutzfeldt W. Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroenterol 1974; 9: 703–710
- McIntosh C HS, Pederson R A, Koop H, Brown J C. Gastric inhibitory polypeptide stimulated secretion of somatostatinlike immunoreactivity from the stomach: inhibition by acetycholine or vagal stimulation. Can J Physiol Pharmacol 1981; 59: 468–172
- Schwartz T W, Stadil F, Chance R E, Rehfeld J F, Larson L-I, Moon N. Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet 1976; i: 1102–1105
- Arnold R, Hülst M V, Neuhof C H, Schwarting H, Becker H D, Creutfeldt W. Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut 1982; 23: 285–291
- Sternberger L A. Immunocytochemistry. Prentice Hall, Englewood Cliffs, NJ 1974
- Sachs L. Angewandte Statistik. Springer, Berlin, Heidelberg, New York 1974
- Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, Wallmark B, Watanabe T, Håkanson R. Plasma gastrin and gastric entero-chromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 391–399
- Creutzfeldt W, Stöckmann F, Conlon J M, Fölsch U R, Bonatz G, Wülfrath M. Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion 1986; 35(Suppl 1)84–97
- Koop H, Willemer S, Steinbach F, Eissele R, Tuch K, Arnold R. Influence of chronic drug-induced achlorhydria by substituted benzimidazoles on the endocrine stomach in rats. Gastroenterology 1987; 92: 406–413
- Festen H PM, Thijs J C, Lamers C BHW, Jansen J MBJ, Pals G, Frants R R, Défize J, Meuwissen S GM. Effects of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 1984; 87: 1030–1034
- Witzel L, Heitz P U, Halter F, Olah A J, Varga L, Werner O, Häcki W H. Effects of prolonged administration of metiamide on serum gastrin, gastrin content of the antrum and gastric corpus, and G-cell population in the rat. Gastroenterology 1979; 76: 945–994
- Tabata K, Okabe S. Gastric secretory conditions and plasma gastrin levels in rats after prolonged treatment with cimetidine. Dig Dis Sci 1984; 29: 40–45
- Arnold R, Creutzfeldt W. Basal and meal-stimulated serum gastrin, antral G-cells and gastrin concentration during cimetidine therapy. Proceedings of the International Symposium on Histamine H2-Receptor Antagonists, W Creutzfeldt. Ex Med, Amsterdam 1978; 87–97
- Ippoliti A, Isenberg J I, Maxwell V, Walsh J H. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology 1976; 70: 488–491
- Konturek S J, Swierczek J S, Kwiecien N, Obtu-Lowicz W, Sito E, Oleksy J. Effect of orally administered 15-(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in patients with duodenal ulcers. Scand J Gastroenterol 1979; 14: 813–819
- Peterson W, Feldman M, Taylor I, Bremer M. The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients. Dig Dis Sci 1979; 24: 381–384
- Mahachai V, Walker K, Sevelius H, Thompson A BR. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease. Gastroenterology 1985; 89: 555–561
- Schulte K, Singer M V, Eysselein V, Demol P, Goebell H. Effect of rioprostil, a synthetic prostaglandin E2 on meal-stimulated gastric acid secretion and plasma gastrin levels in humans. Digestion 1987; 36: 162–167
- Shriver D A, Katz L B, Rosenthale M E. Gastric antisecretory and antigastrolesive pharmacology of rioprostil. Scand J Gastroenterol 1989; 10–20, suppl. 164
- Tytgat G NJ, Offerhaus G JA, van Minnen A J, Everts V, Hensen-Logmans S C, Samson G. Influence of oral 15(R)-15 methyl prostaglandin E2 on human gastric mucosa. A light microscopic, cell kinetic, and ultrastructural study. Gastroenterology 1986; 90: 1111–1120
- Schusdziarra V, Rouiller D, Jaffe B M, Harris V, Unger R H. Effect of exogenous and endogenous prostaglandin E upon gastric endocrine function in dogs. Endocrinology 1980; 106: 1620–1627
- Schwartz T W. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983; 85: 1411–1425